(2021) Erratum: SD1000: High Sustained Viral Response Rate in 1361 Patients with Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial (Clin Infect Dis (2020) 70:10 (2206-2212) DOI: 10.1093/cid/ciz628). Clinical Infectious Diseases. p. 172. ISSN 10584838 (ISSN)
Full text not available from this repository.
Abstract
Upon the original publication of this article Merat S. SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial. Clin Infect Dis 2020;70(10):2206 2212. https://doi.org/10.1093/cid/ciz628, the members of SD1000 research team as shown in the Appendix were not correctly tagged with their affiliations under the SD1000 Research Team contributor group. The details have been corrected only in this erratum (as shown below) to preserve the published version of record. The publisher regrets this error. SD1000 Research Team Contributor Group:. © 2021 Oxford University Press. All rights reserved.
| Item Type: | Article |
|---|---|
| Keywords: | erratum |
| Divisions: | |
| Page Range: | p. 172 |
| Journal or Publication Title: | Clinical Infectious Diseases |
| Journal Index: | Scopus |
| Volume: | 73 |
| Number: | 1 |
| Identification Number: | https://doi.org/10.1093/cid/ciaa1768 |
| ISSN: | 10584838 (ISSN) |
| Depositing User: | مهندس مهدی شریفی |
| URI: | http://eprints.mubam.ac.ir/id/eprint/1324 |
Actions (login required)
 |
View Item |